Ilmarinen Mutual Pension Insurance Co decreased its holdings in Procter & Gamble Company (The) (NYSE:PG - Free Report) by 7.0% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 417,000 shares of the company's stock after selling 31,500 shares during the quarter. Procter & Gamble accounts for about 0.5% of Ilmarinen Mutual Pension Insurance Co's holdings, making the stock its 27th biggest holding. Ilmarinen Mutual Pension Insurance Co's holdings in Procter & Gamble were worth $59,760,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds have also recently bought and sold shares of the stock. Moors & Cabot Inc. grew its stake in Procter & Gamble by 1.7% during the 4th quarter. Moors & Cabot Inc. now owns 143,350 shares of the company's stock worth $20,543,000 after purchasing an additional 2,393 shares in the last quarter. EagleClaw Capital Managment LLC grew its stake in Procter & Gamble by 1.7% during the 4th quarter. EagleClaw Capital Managment LLC now owns 8,925 shares of the company's stock worth $1,279,000 after purchasing an additional 150 shares in the last quarter. Intech Investment Management LLC lifted its stake in Procter & Gamble by 8.4% in the fourth quarter. Intech Investment Management LLC now owns 85,592 shares of the company's stock worth $12,266,000 after acquiring an additional 6,601 shares during the last quarter. Houlihan Financial Resource Group Ltd. lifted its stake in Procter & Gamble by 73.0% in the fourth quarter. Houlihan Financial Resource Group Ltd. now owns 4,722 shares of the company's stock worth $698,000 after acquiring an additional 1,993 shares during the last quarter. Finally, CFS Investment Advisory Services LLC lifted its stake in Procter & Gamble by 3.2% in the fourth quarter. CFS Investment Advisory Services LLC now owns 28,864 shares of the company's stock worth $4,136,000 after acquiring an additional 892 shares during the last quarter. 65.77% of the stock is owned by institutional investors and hedge funds.
Procter & Gamble News Roundup
Here are the key news stories impacting Procter & Gamble this week:
Analysts Set New Price Targets
A number of brokerages recently issued reports on PG. Piper Sandler lifted their price target on shares of Procter & Gamble from $142.00 to $145.00 and gave the stock a "neutral" rating in a research note on Friday, April 24th. JPMorgan Chase & Co. decreased their price target on shares of Procter & Gamble from $165.00 to $162.00 and set an "overweight" rating for the company in a research note on Friday, April 17th. Evercore set a $162.00 price target on shares of Procter & Gamble in a research note on Monday, April 27th. Royal Bank Of Canada decreased their price target on shares of Procter & Gamble from $172.00 to $167.00 and set an "outperform" rating for the company in a research note on Thursday, April 9th. Finally, TD Cowen lifted their price target on shares of Procter & Gamble from $142.00 to $150.00 and gave the stock a "hold" rating in a research note on Monday, April 27th. Eleven research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $161.06.
Read Our Latest Stock Report on PG
Procter & Gamble Stock Down 1.0%
Shares of NYSE:PG opened at $146.07 on Friday. The company has a market capitalization of $340.14 billion, a PE ratio of 21.36, a P/E/G ratio of 6.32 and a beta of 0.41. The company has a current ratio of 0.73, a quick ratio of 0.53 and a debt-to-equity ratio of 0.44. Procter & Gamble Company has a twelve month low of $137.62 and a twelve month high of $170.99. The firm has a 50 day simple moving average of $144.47 and a 200-day simple moving average of $147.92.
Procter & Gamble (NYSE:PG - Get Free Report) last issued its quarterly earnings data on Friday, April 24th. The company reported $1.59 earnings per share for the quarter, topping the consensus estimate of $1.56 by $0.03. Procter & Gamble had a net margin of 19.16% and a return on equity of 32.00%. The business had revenue of $21.24 billion during the quarter, compared to the consensus estimate of $21.52 billion. During the same quarter in the previous year, the firm earned $1.54 EPS. The company's revenue was up 7.4% compared to the same quarter last year. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. On average, equities analysts predict that Procter & Gamble Company will post 6.91 EPS for the current fiscal year.
Procter & Gamble Increases Dividend
The firm also recently declared a quarterly dividend, which was paid on Friday, May 15th. Investors of record on Friday, April 24th were given a $1.0885 dividend. This is a positive change from Procter & Gamble's previous quarterly dividend of $1.06. The ex-dividend date was Friday, April 24th. This represents a $4.35 annualized dividend and a yield of 3.0%. Procter & Gamble's payout ratio is currently 63.60%.
Procter & Gamble Company Profile
(
Free Report)
Procter & Gamble NYSE: PG is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world's largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.
P&G's product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.
Read More
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PG - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2026 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.